Compositions and methods for the treatment of a beta-catenin-associated disease or disorder
Disclosed herein are methods for the treatment of cancer, comprising administering to a subject a β-catenin nucleic acid inhibitor molecule and a therapeutically effective amount of an MEK inhibitor or a c-Myc nucleic acid inhibitor molecule. Also disclosed herein is a pharmaceutical composition com...
Saved in:
| Main Authors | , |
|---|---|
| Format | Patent |
| Language | English |
| Published |
03.11.2020
|
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | Disclosed herein are methods for the treatment of cancer, comprising administering to a subject a β-catenin nucleic acid inhibitor molecule and a therapeutically effective amount of an MEK inhibitor or a c-Myc nucleic acid inhibitor molecule. Also disclosed herein is a pharmaceutical composition comprising a therapeutically effective amount of a β-catenin nucleic acid inhibitor molecule; a therapeutically effective amount of an MEK inhibitor or a c-Myc nucleic acid inhibitor molecule and at least one pharmaceutical carrier. |
|---|---|
| AbstractList | Disclosed herein are methods for the treatment of cancer, comprising administering to a subject a β-catenin nucleic acid inhibitor molecule and a therapeutically effective amount of an MEK inhibitor or a c-Myc nucleic acid inhibitor molecule. Also disclosed herein is a pharmaceutical composition comprising a therapeutically effective amount of a β-catenin nucleic acid inhibitor molecule; a therapeutically effective amount of an MEK inhibitor or a c-Myc nucleic acid inhibitor molecule and at least one pharmaceutical carrier. |
| Author | Ganesh, Shanthi Abrams, Marc |
| Author_xml | – fullname: Abrams, Marc – fullname: Ganesh, Shanthi |
| BookMark | eNqNizsOwkAMBbeAgt8dzAEisaGhJgLRAxVFZLIvykrEjta-v0jBAajejDRvHRaiglV4NTpOatmzihFLohE-aDLqtZAPIC9gHyFO2hPTG85Vxw7JUrGZdnmWRCkb2EDza0YtCWUblj1_DLvfbsL-enk0twqTtrCJOwi8fd7j4VTHGOtzffyn-QK4Hj1H |
| ContentType | Patent |
| DBID | EVB |
| DatabaseName | esp@cenet |
| DatabaseTitleList | |
| Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine Chemistry Sciences |
| ExternalDocumentID | US10821112B2 |
| GroupedDBID | EVB |
| ID | FETCH-epo_espacenet_US10821112B23 |
| IEDL.DBID | EVB |
| IngestDate | Fri Jul 19 14:29:49 EDT 2024 |
| IsOpenAccess | true |
| IsPeerReviewed | false |
| IsScholarly | false |
| Language | English |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-epo_espacenet_US10821112B23 |
| Notes | Application Number: US201716084852 |
| OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20201103&DB=EPODOC&CC=US&NR=10821112B2 |
| ParticipantIDs | epo_espacenet_US10821112B2 |
| PublicationCentury | 2000 |
| PublicationDate | 20201103 |
| PublicationDateYYYYMMDD | 2020-11-03 |
| PublicationDate_xml | – month: 11 year: 2020 text: 20201103 day: 03 |
| PublicationDecade | 2020 |
| PublicationYear | 2020 |
| RelatedCompanies | Dicerna Pharmaceuticals, Inc |
| RelatedCompanies_xml | – name: Dicerna Pharmaceuticals, Inc |
| Score | 3.2923772 |
| Snippet | Disclosed herein are methods for the treatment of cancer, comprising administering to a subject a β-catenin nucleic acid inhibitor molecule and a... |
| SourceID | epo |
| SourceType | Open Access Repository |
| SubjectTerms | BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS THEREOF CULTURE MEDIA ENZYMOLOGY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY MICROBIOLOGY MICROORGANISMS OR ENZYMES MUTATION OR GENETIC ENGINEERING PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS SPIRITS VINEGAR WINE |
| Title | Compositions and methods for the treatment of a beta-catenin-associated disease or disorder |
| URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20201103&DB=EPODOC&locale=&CC=US&NR=10821112B2 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1bS8MwFD6MKeqbTkXnhQjSt2DXdG19KEJvDGEX3CoDH0Z6g_mQDlvx73sa080XfQsJCckJX86XnEsA7o3EZOmQOzRH8kpNW3cozxijaaobBeoDbsmgsPHEGsXm83K47MB7Gwsj84R-yeSIiKgU8V7L83qze8QKpG9l9ZCssap8ihZuoKnbsdRmTAs8N5xNg6mv-b4bz7XJC3JdB686A8PD43oPabTdoCF89ZqolM1vlRIdw_4MRxP1CXRy0YNDv_15rQcHY2XwxqLCXnUKbw10WxcrwkVGfn5_rgjyToI8jmydxklZEE4SXAFtHJ7EWlCutiHPiLLJEOyVqdybZ3AXhQt_RHGWq61IVvF8tyB2Dl1RivwCCLMLvTBlTjAE50DnPCly_thYvxzLtLJL6P89Tv-_xis4asQro_DYNXTrj8_8BtVxndxKOX4DeAKPOA |
| link.rule.ids | 230,309,783,888,25576,76876 |
| linkProvider | European Patent Office |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3NS8MwFH-MKc6bTkXnVwTpLdg1XVsPRVi7MXXthttk4KGkbQrzkA1b8d_3NXabF72FhITkhV_eL3kfAbg1YpMlHe5QgeSVmrbuUJ4yRpNENzLUB9xSQWFBaA1m5tO8M6_B-zoWRuUJ_VLJERFRCeK9UOf1avuI5SvfyvwuXmDV8qE_dX2tuh0rbcY0v-v2xiN_5Gme584mWviCXNfBq07b6OJxvYMU2y7R0HvtllEpq98qpX8Au2McTRaHUBOyCQ1v_fNaE_aCyuCNxQp7-RG8ldBdu1gRLlPy8_tzTpB3EuRxZOM0TpYZ4STGFdDS4UkuJOXVNoiUVDYZgr3SKvfmMdz0e1NvQHGW0UYk0WyyXRA7gbpcSnEKhNmZnpkqJxiCs61zHmeC35fWL8cyrfQMWn-P0_qv8Roag2kwjIaP4fM57JeiVhF57ALqxcenuETVXMRXSqbfXHWSKw |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=Compositions+and+methods+for+the+treatment+of+a+beta-catenin-associated+disease+or+disorder&rft.inventor=Abrams%2C+Marc&rft.inventor=Ganesh%2C+Shanthi&rft.date=2020-11-03&rft.externalDBID=B2&rft.externalDocID=US10821112B2 |